• 1. Nanshan School, Guangzhou Medical University, Guangzhou, 511436, P.R.China;
  • 2. Guangzhou Institute of Respiratory Health, State Key Laboratory of Respiratory Disease, First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510120, P.R.China;
JIANG Mei, Email: jiangmei927@163.com
Export PDF Favorites Scan Get Citation

Objectives To assess the methodological quality of Chinese clinical practice guidelines (CPGs) for respiratory diseases published in 2017, so as to provide evidence for developing and updating CPGs of this field in the future.Methods WanFang Data, CNKI, VIP, CBM databases, Medlive and other related websites were electronically searched to collect Chinese CPGs for respiratory diseases published from January 2017 to December 2017. Four reviewers independently evaluated the quality of eligible guidelines by using Appraisal of Guidelines for Research and Evaluation Ⅱ (AGREE Ⅱ) instrument.Results A total of 37 guidelines were included. The mean scores of the six AGREE Ⅱ domains (scope and purpose, stakeholder involvement, rigor of development, clarity and presentation, applicability, editorial independence) were 59.3%, 25.1%, 10.8%, 59.1%, 25.8%, and 7.3%, respectively. Only 1 guideline (2.7%) was recommended for clinical use, and 2 guidelines (5.4%) were recommended with modification.Conclusions The CPGs for respiratory diseases published in China in 2017 have higher quality than CPGs published prior to 2017, however great discrepancies exist when comparing with international guidelines of average level. More attention should be paid on the rigorousness of methodology and the practicality of content in the future development of CPGs.

Citation: WAN Kairui, LI Yao, WU Junwan, ZOU Bangyu, JIANG Mei. Quality assessment of clinical practice guidelines for respiratory diseases in China in 2017. Chinese Journal of Evidence-Based Medicine, 2019, 19(6): 715-722. doi: 10.7507/1672-2531.201811100 Copy

  • Previous Article

    Characteristics of the methodological studies on patient compliance in clinical trials in China
  • Next Article

    Quality assessment of clinical practice guidelines on Chinese rehabilitation medicine